The adjusted HR per 1 SD increase in serum VAP-1 concentrations were 1.28 for cancer incidence (95% CI = 1.01–1.62), 1.60 for cancer mortality (95% CI = 1.14–2.23), and 1.38 for all-cause mortality (95% CI = 1.09–1.75). The gene discussed is AOC3; the disease is cancer.